Article
Intermittent Levosimendan Administration for Advanced Heart Failure Treatment in Adults with Congenital Heart Disease
2026-02-12
Abstract excerpt
<h4>Background: </h4> Heart failure (HF) is a major cause of morbidity in adults with congenital heart disease (ACHD), who may also have limited access to transplant. Intermittent levosimendan has shown benefit in advanced HF due to acquired heart disease, but currently there are no data in ACHD. <h4>Methods:</h4> We conducted a retrospective analysis of ACHD patients aged >18 years with advanced HF who receive...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e9126166-fde7-5e8c-93a7-4d23f25986db
- DOI
- 10.20944/preprints202602.0999.v1
